Top Leveraged ETFs of Last Week

A rise in coronavirus cases globally was the primary reason for the declines. Against this backdrop, we highlight a few leveraged ETFs that gained in the week.

A rise in coronavirus cases globally was the ...

3 Stocks Immune to the Coronavirus Downturn

Investors should still be on the hunt for stocks that appear immune to the broader coronavirus fallout that has put a halt to many aspects of the economy.

Investors should still be on the hunt for ...

Will This Drug End Coronavirus?

Part of a family of drugs called antihelmintics, it works by paralyzing and killing roundworms and related infections in people with impaired/weakened immune systems.

Part of a family of drugs called antihelmintics, ...

New Strong Buy Stocks for April 6th

This company that designs, manufactures, and sells semiconductor platform solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 36.9% over the last 60 days.

This company that designs, manufactures, and sells semiconductor ...

Top Stock Reports for J&J, Merck, Novartis & Others

Today's Research Daily features new research reports on 16 major stocks, including JNJ, MRK and NVS.

Today's Research Daily features new research reports on 16 ...

Where Might Our Next 'Heroes' Be? Global Week Ahead

Disastrous jobless figures tarnish the week's econ data. Meanwhile, investors who need returns to meet pension or insurance liabilities are seeking 'dividend heroes,' and Swiss banks might take that role.

Disastrous jobless figures tarnish the week's econ data. ...

AWS 4/6: Global Positivity Sends Pre-Markets Much Higher

Even the rate of cases in New York -- now considered the epicenter of COVID-19 -- has dropped over the last two days.

Even the rate of cases in New York ...

PFP 4/6: Outbreak Expected to Peak Mid-April

The sooner we get thru this, with the least amount of damage, the bigger and faster our recovery will be.

The sooner we get thru this, with the ...